Nasdaq

Becton Dickinson to Pay $175 Million for Misleading Investors About Alaris Infusion Pump

Washington, D.C.--(Newsfile Corp. - December 16, 2024) - The Securities and Exchange Commission today announced settled charges against Becton, Dickinson and Company, a New Jersey-based medical device ...
FierceBiotech

FDA doles out Class I rating to recall of replacement part for BD's Alaris infusion pump

A new group of recalls for a repair piece installed in some of BD’s Alaris infusion pumps joins more than a dozen others on the long list of serious recalls involving the device in the last decade.
Crain's Detroit

Infusion pump recall has hospitals scrambling whether to replace, repair them

Gift Article 10 Remaining As a subscriber, you have 10 articles to gift each month. Gifting allows recipients to access the article for free. A voluntary safety recall of widely used Alaris infusion ...
Yahoo Finance

BD expands Class I recall to cover 15 more Alaris pump infusion sets

This story was originally published on MedTech Dive. To receive daily news and insights, subscribe to our free daily MedTech Dive newsletter. BD has expanded a Class I Alaris recall to cover 15 ...
Hosted on MSN

BD expands recall of its Alaris Pump Module model 8100

The U.S. FDA said that BD (NYSE:BDX) has expanded its Class I voluntary recall to inform customers about the worst-case performance of the BD Alaris Pump Module model 8100 when used with certain ...
Healio

FDA clears updated Alaris infusion pump; recall remediation remains ‘top priority’

Please provide your email address to receive an email when new articles are posted on . The FDA granted 510(k) clearance to Becton Dickinson’s updated Alaris infusion pump, allowing the company to ...
FierceBiotech

With updated FDA nod, BD aims to revive beleaguered Alaris infusion pumps

Since the start of 2020, BD’s Alaris infusion pumps have been the subject of more than half-a-dozen Class I hardware and software recalls, a handful of cybersecurity warnings and a years-long ...